تدخلات سلوكية مع وبدون علاج دوائي: دراسة مقارنة في مركز للتوحد في الأردن

(APA), A.P.A. Autism spectrum disorder. 2022 [cited 2022 6/2022]; Available from:

https://www.apa.org/topics/autism-spectrum-disorder.

WHO. Autism. 2022 5/30/2022]; Available from: https://www.who.int/news-room/fact-sheets/detail/autism-spectrum-disorders.

Zeidan, J., et al. Global prevalence of autism: A systematic review update. Autism Res. 2022; 15(5):778-790. DOI: https://doi.org/10.1002/aur.2696

Hodges, H., C. Fealko, and N. Soares, Autism spectrum disorder: definition, epidemiology, causes, and clinical evaluation. Transl Pediatr. 2020. 9(Suppl 1):S55-S65. DOI: https://doi.org/10.21037/tp.2019.09.09

(CDC), C.f.D.C.a.p. Increase in Devlopmental Disabilities Among Children in the United States. Developmental Disabilities [cited 2022; Available from: https://www.cdc.gov/ncbddd/developmentaldisabilities/features/increase-in-developmental-disabilities.html.

Benjamin Zablotsky, L.I.B., Matthew J. Maenner, Laura A. Schieve,

a. Melissa L. Danielson, Rebecca H. Bitsko, Stephen J. Blumberg, Michael D. Kogan, Coleen A. Bo. Prevalence and Trends of Developmental Disabilities among Children in the United States: 2009–2017. Pediatrics. 144(4).

Lai, M.C., et al. Evidence-based support for autistic people across the lifespan: maximising potential, minimising barriers, and optimising the person-environment fit. Lancet Neurol. 2020; 19(5):434-451. DOI: https://doi.org/10.1016/S1474-4422(20)30034-X

James, S.N. and C.J. Smith, Early Autism Diagnosis in the Primary Care Setting. Semin Pediatr Neurol. 2020. 35:100827. DOI: https://doi.org/10.1016/j.spen.2020.100827

Chiarotti, F. and A. Venerosi. Epidemiology of autism spectrum disorders: a review of worldwide prevalence estimates since 2014. Brain sciences. 2020; 10(5):274. DOI: https://doi.org/10.3390/brainsci10050274

Alzghoul, L., et al. The association between levels of inflammatory markers in autistic children compared to their unaffected siblings and unrelated healthy controls. Turkish journal of medical sciences. 2019; 49(4):1047-1053. DOI: https://doi.org/10.3906/sag-1812-167

Christensen, D.L., et al. Prevalence and characteristics of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, United States, 2012. MMWR Surveillance Summaries. 2018; 65(13):1. DOI: https://doi.org/10.15585/mmwr.ss6513a1

Napolitano, A., et al. Sex Differences in Autism Spectrum Disorder: Diagnostic, Neurobiological, and Behavioral Features. Front Psychiatry. 2022; 13:889636. DOI: https://doi.org/10.3389/fpsyt.2022.889636

Association, A.P. Autism-Spectrum-Disorder. 2022.

Carbone, P.S., et al. Primary Care Autism Screening and Later Autism Diagnosis. Pediatrics. 2020; 146(2). DOI: https://doi.org/10.1542/peds.2019-2314

van 't Hof, M., et al. Age at autism spectrum disorder diagnosis: A systematic review and meta-analysis from 2012 to 2019. Autism.; 2021; 25(4):862-873. DOI: https://doi.org/10.1177/1362361320971107

Lord, C., et al., Autism spectrum disorder. Lancet, 2018. 392(10146): p. 508-520. DOI: https://doi.org/10.1016/S0140-6736(18)31129-2

Hyman, S.L., et al. Identification, Evaluation, and Management of Children With Autism Spectrum Disorder. Pediatrics. 2020; 145(1). DOI: https://doi.org/10.1542/9781610024716-part01-ch002

Bal, V.H., et al., Autism spectrum disorder symptoms from ages 2 to 19 years: Implications for diagnosing adolescents and young adults. Autism Res. 2019. 12(1):89-99. DOI: https://doi.org/10.1002/aur.2004

Magiati, I., X.W. Tay, and P. Howlin. Cognitive, language, social and behavioural outcomes in adults with autism spectrum disorders: a systematic review of longitudinal follow-up studies in adulthood. Clin Psychol Rev. 2014; 34(1):73-86. DOI: https://doi.org/10.1016/j.cpr.2013.11.002

Esbensen, A.J., et al. Age-related differences in restricted repetitive behaviors in autism spectrum disorders. J Autism Dev Disord. 2009; 39(1):57-66. DOI: https://doi.org/10.1007/s10803-008-0599-x

Eissa, N., et al. Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder. Front Neurosci. 2018; 12:304. DOI: https://doi.org/10.3389/fnins.2018.00304

Cheroni, C., N. Caporale, and G. Testa. Autism spectrum disorder at the crossroad between genes and environment: contributions, convergences, and interactions in ASD developmental pathophysiology. Mol Autism. 2020; 11(1):69. DOI: https://doi.org/10.1186/s13229-020-00370-1

Alhawamdeh, E., et al. A Cross-sectional Study of the Catalase Genetic Polymorphism (-262 cytosine/ thymine) and Blood Catalase Activity among Jordanian Vitiligo Patients. Jordan Journal of Pharmaceutical Sciences. 2023; 330-344. DOI: https://doi.org/10.35516/jjps.v16i2.438

Panisi, C., et al., Autism Spectrum Disorder from the Womb to Adulthood: Suggestions for a Paradigm Shift. J Pers Med, 2021. 11(2).

Hansen, S.N., et al. Recurrence Risk of Autism in Siblings and Cousins: A Multinational, Population-Based Study. J Am Acad Child Adolesc Psychiatry, 2019; 58(9):866-875. DOI: https://doi.org/10.1016/j.jaac.2018.11.017

Emberti Gialloreti, L., et al. Risk and Protective Environmental Factors Associated with Autism Spectrum Disorder: Evidence-Based Principles and Recommendations. J Clin Med. 2019; 8(2). DOI: https://doi.org/10.3390/jcm8020217

Masini, E., et al. An Overview of the Main Genetic, Epigenetic and Environmental Factors Involved in Autism Spectrum Disorder Focusing on Synaptic Activity. Int J Mol Sci. 2020; 21(21). DOI: https://doi.org/10.3390/ijms21218290

Zwaigenbaum, L., et al. Early Intervention for Children With Autism Spectrum Disorder Under 3 Years of Age: Recommendations for Practice and Research. Pediatrics. 2015; 136 Suppl 1:S60-81. DOI: https://doi.org/10.1542/peds.2014-3667E

Anagnostou, E., Clinical trials in autism spectrum disorder: evidence, challenges and future directions. Curr Opin Neurol. 2018; 31(2):119-125. DOI: https://doi.org/10.1097/WCO.0000000000000542

LeClerc, S. and D. Easley. Pharmacological therapies for autism spectrum disorder: a review. P T. 2015; 40(6):389-97.

DeFilippis, M. and K.D. Wagner, Treatment of Autism Spectrum Disorder in Children and Adolescents. Psychopharmacol Bull. 2016; 46(2):18-41.

Masri, A.T., et al. Parental use of conventional and complementary therapy for autism in Jordan. Complement Ther Med. 2020; 48:102275. DOI: https://doi.org/10.1016/j.ctim.2019.102275

Makrygianni, M.K., et al. The effectiveness of applied behavior analytic interventions for children with Autism Spectrum Disorder: A meta-analytic study. Research in Autism Spectrum Disorders. 2018; 51:18-31. DOI: https://doi.org/10.1016/j.rasd.2018.03.006

Yu, Q., et al. Efficacy of Interventions Based on Applied Behavior Analysis for Autism Spectrum Disorder: A Meta-Analysis. Psychiatry Investig. 2020; 17(5):432-443. DOI: https://doi.org/10.30773/pi.2019.0229

Ibrahim Alabbadi, E.M., Nashaat Taani, Safwan Dababneh, Qasem Shersheer, Omar Nimri, Refqi Mahmoud, Rami Hijazeen, Adnan Ishaq, Exploring the Economic Aspects of β-Thalassemia in Jordan in 2019. Jordan Journal of Pharmaceutical Sciences. 2022; 15(3). DOI: https://doi.org/10.35516/jjps.v15i3.412

Mayasah Al-Nema, A.G. Schizophrenia: The Ambiguous Mechanism behind the Disorder. Jordan Journal of Pharmaceutical Sciences. 2022; 15(2). DOI: https://doi.org/10.35516/jjps.v15i2.323

Goel, R., et al. An update on pharmacotherapy of autism spectrum disorder in children and adolescents. Int Rev Psychiatry. 2018; 30(1):78-95. DOI: https://doi.org/10.1080/09540261.2018.1458706

Loomes, R., L. Hull, and W.P.L. Mandy, What Is the Male-to-Female Ratio in Autism Spectrum Disorder? A Systematic Review and Meta-Analysis. J Am Acad Child Adolesc Psychiatry. 2017; 56(6):466-474. DOI: https://doi.org/10.1016/j.jaac.2017.03.013

Ozonoff, S., et al., Recurrence risk for autism spectrum disorders: a Baby Siblings Research Consortium study. Pediatrics. 2011; 128(3):e488-95. DOI: https://doi.org/10.1542/peds.2010-2825

Yip, B.H.K., et al. Caesarean section and risk of autism across gestational age: a multi-national cohort study of 5 million births. Int J Epidemiol. 2017. 46(2):429-439. DOI: https://doi.org/10.1093/ije/dyw336

Stepanova, E., et al. Pharmacotherapy of emotional and behavioral symptoms associated with autism spectrum disorder in children and adolescents. Dialogues Clin Neurosci. 2017; 19(4):395-402. DOI: https://doi.org/10.31887/DCNS.2017.19.4/rfindling

Mano-Sousa, B.J., et al. Effects of Risperidone in Autistic Children and Young Adults: A Systematic Review and Meta-Analysis. Curr Neuropharmacol. 2021; 19(4):538-552. DOI: https://doi.org/10.2174/1570159X18666200529151741

Hollander, E., et al. Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders. Neuropsychopharmacology. 2010; 35(4):990-8. DOI: https://doi.org/10.1038/npp.2009.202

Frazier, T.W., et al. Effectiveness of medication combined with intensive behavioral intervention for reducing aggression in youth with autism spectrum disorder. J Child Adolesc Psychopharmacol. 2010; 20(3):167-77. DOI: https://doi.org/10.1089/cap.2009.0048